Toronto Dominion Bank
CRDL

Toronto Dominion Bank’s Cardiol Therapeutics CRDL Stock Holding History

Toronto Dominion Bank’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1
Closed -$1 – 1563
2024
Q4 		$1 Buy
+1
New +$2 ﹤0.01% 1523
2024
Q3 		– Sell
-803
Closed -$1.62K – 1215
2024
Q2 		$1.62K Buy
803
+700
+680% +$1.49K ﹤0.01% 1222
2024
Q1 		$186 Sell
103
-130
-56% -$175 ﹤0.01% 1296
2023
Q4 		$196 Buy
233
+207
+796% +$176 ﹤0.01% 1405
2023
Q3 		$23 Buy
+26
New +$25 ﹤0.01% 1781
2023
Q2 		– Sell
-575
Closed – – 1539
2023
Q1 		$0 Buy
+575
New +$340 ﹤0.01% 1479
2022
Q1 		– Sell
-262
Closed – – 1521
2021
Q4 		$0 Sell
262
-620
-70% -$1.71K ﹤0.01% 1586
2021
Q3 		$4K Buy
+882
New +$3.2K ﹤0.01% 1304

Other funds holding CRDL

TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
LSA
Lion Street Advisors Austin, Texas $289M AUM 3.13% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $8.94B AUM 20.84% 1-Year Est. Return
MOS
MGO One Seven Beachwood, Ohio $4.98B AUM 22.72% 1-Year Est. Return

Toronto Dominion Bank's CRDL Position: Q1 2025 in Review

Toronto Dominion Bank sold out of Cardiol Therapeutics (CRDL) in Q1 2025, closing a stake of 1 share — an estimated $1 sold.

Toronto Dominion Bank first reported a position in CRDL in Q3 2021 and held it in 8 quarters. The position peaked at $4K in Q3 2021. 38 funds tracked by Wall St. Rank hold CRDL as of Q1 2025.

  • Toronto Dominion Bank reported no remaining Cardiol Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Toronto Dominion Bank sold 1 Cardiol Therapeutics share in Q1 2025, an estimated $1.
  • Toronto Dominion Bank first reported a position in Cardiol Therapeutics in Q3 2021 and held it in 8 quarters.
  • Toronto Dominion Bank's Cardiol Therapeutics position peaked at $4K in Q3 2021.
  • 38 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q1 2025.

Based on Toronto Dominion Bank's 13F filing for Q1 2025, filed 15 May 2025.